Attention: Restrictions on use of AUA, AUAER, and UCF content in third party applications, including artificial intelligence technologies, such as large language models and generative AI.
You are prohibited from using or uploading content you accessed through this website into external applications, bots, software, or websites, including those using artificial intelligence technologies and infrastructure, including deep learning, machine learning and large language models and generative AI.
BCG Phone Script
BCG Phone Script for Member Offices (60 seconds)
Could also be posted as a message on Member websites
Bacillus Calmette-Guérin, otherwise known as BCG, is a standard treatment option for non-muscle invasive bladder cancer.
Merck & Company is the only maker and supplier of BCG to the United States. They have informed us there is a global shortage of this product and they expect the shortage to continue through the end of 2019.
We understand this situation may be stressful to those who rely on this drug, and we are sorry. Please understand that we are working with suppliers in order to provide the best possible care for our patients. We encourage you to talk to your provider about alternative treatment options to BCG while this shortage continues. We will continue to keep you updated as more news becomes available.
Several national organizations, including the American Urological Association, are staying in close contact with the U.S. Food and Drug Administration who is working to identify and approve other sources of BCG.
For further information about BCG, please feel free to reach out to Merck’s National Service Center at 1-800-444-2080.
advertisement
advertisement